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Thesis Abstract
Elliott, Karen, M .S., December 2002 Health and Hum an Performance
Internal Health Locus of Control: A Description of H igh and Low Orientation 
and Approaches to Coping with Scleroderma.
Committee Chair: K. Ann Sondag, Ph.D.
The purpose o f this study was to describe individuals’ approaches to 
coping with their illness as it relates to their health locus o f control. Information 
was obtained through various sources. The M ultidim ensional Health Locus o f 
Control Survey (MHLC) was used to identify a participant’s health locus of 
control orientation within three subscales, internal, external and powerful others. 
Participants were sorted into two groups. H igh ILOC and Low ILOC. The 
Narrative Response Questionnaire was used to describe participants’ approaches 
to coping with their scleroderma as it relates to either high or low internal health 
locus o f control. A  demographic page was also developed to collect 
demographics, length of diagnosis, type o f scleroderma, length o f support group 
attendance and overall health status.
Descriptive statistics were used to provide a sum m ary o f the results o f the 
demographic page. The results o f the NRQ were reported through qualitative 
analysis and described within the two groups. Themes or sim ilar thoughts were 
identified with participants’ responses in the High ILO C group and the Low ILOC 
group. Because o f the uneven distribution o f participants between the two 
groups, only limited comparisons and contrasts could be m ade between the High- 
ILOC Group and the Low ILOC Group.
Information from this study provides the scleroderm a support group 
members, group facilitators and the Scleroderma Foundation with a greater 
understanding o f the role that the health locus o f control plays in individuals’ 
perceptions and coping behaviors related to their illness.
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CHAPTER I 
Introduction to the Study
Scleroderma affects approximately 300,000 people in the United States. 
The com mon age o f onset ranges from  30-50 years old, w ith women 
approximately 4 times more likely to be affected than men. W ithin the past three 
decades, there has been an increase in incidence o f  the disease (M alcame, 2002). 
People with this disease, diagnosed and undiagnosed, need to see a variety of 
health specialists and experiment with diverse medications and treatments 
(Scleroderma Research Foundation, 2002).
The cause o f scleroderma is not known. There is no cure for scleroderma 
and there is no one standard treatment for the disease. There is also no specific 
test to diagnose scleroderma. Diagnosis requires a variety o f tests and procedures. 
To diagnose the disease, it is important to piece together the various test results 
with the individual’s symptoms. If  this is not done, the disease remains 
undiagnosed, allowing for the possibility o f m any undetected cases in the United 
States (Scleroderma Research Foundation, 2002). M ore attention needs to be 
focused on scleroderma in order to create definitive diagnostic options and 
treatment plans (W asko & Medsger, 2000).
W hile im proving the diagnosis and treatm ent o f scleroderm a is important, 
it is also important to shed light onto the unexplored psychosocial dimensions of 
the disease (M alcame, 2002). One approach to the study o f the psychosocial 
aspects o f chronic diseases like scleroderm a has been through the application of 
the Health Locus o f Control Theory. This theory, derived from  the Social 
Learning Theory, states that individuals’ perceptions o f control over their health is
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
either predominately internal or external and affects their coping behaviors 
(Sanders & Sul, 1982). This location or “locus” o f a person’s control can be 
measured by the M ultidimensional Health Locus o f Control Survey (M HLC). The 
M HLC was used in this study to categorize participants into one of two groups. 
The first group. High E.OC, consisted o f individuals w ho scored high on the 
internal health locus of control scale. The second group. Low BLOC, consisted o f 
those who scored low on the internal health locus o f  control scale.
In order to explore the relationship between locus o f  control and health 
related coping behaviors in people w ith scleroderma, the researcher developed the 
Narrative Response Questionnaire (NRQ). The NRQ asks respondents to explain 
the cause o f their disease and to describe the various actions they are taking to 
cope with their disease. The NRQ was used to describe the coping actions o f the 
participants for both the High BLOC and the Low BLOC groups. Awareness o f 
coping behaviors o f individuals as they relate to locus o f  control may provide 
information that can help scleroderma patients cope w ith their disease.
Statem ent o f Purpose 
There is a lack o f inform ation regarding scleroderm a patients and their 
ability to cope with their disease. The purpose o f this study was to describe 
individuals’ approaches to coping with their illness as it relates to their health 
locus o f control.
Research Q uestions
1. High internal locus o f control orientation on the MHLC:
a) How do participants who score high on internal health locus o f control 
explain the cause o f their disease?
b) How do participants who score high on internal health locus o f control 
describe the effects o f their disease in their lives?
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
c) W hat actions do the participants who score high on internal health locus 
o f control take in regard to dealing with their disease?
2. Low internal locus o f control orientation on the MHLC:
a) How do participants who score low  on internal health locus o f  control 
explain the cause of their disease?
b) How do participants who score low on internal health locus of control 
describe the effects o f  their disease on their lives?
c) W hat actions do the participants who score low on internal health locus 
o f control take in regard to dealing w ith their disease?
3. W hat is the relationship between a high or low internal locus o f control 
and perception o f overall health status?
Significance o f the Study  
M ost research reviewed regarding scleroderm a is focused on m edically 
determining the cause and cure o f the disease through exploring human 
physiology. In order, however, to gain a com plete picture o f scleroderma, this 
important emphasis needs to be coupled w ith an examination o f the psychosocial 
dynamics o f this disease. Information from  this study provides the scleroderma 
support group members, group facilitators and the Scleroderma Foundation w ith a 
greater understanding o f the role that the health locus o f control plays in 
individuals’ perceptions and coping behaviors.
Delim itations 
The delimitations o f this study were:
1. The study was delim ited to scleroderm a patients attending support 
groups through the Scleroderm a Foundation.
2. Data was collected via m ailed surveys and questionnaires.
3. The data was restricted to participants’ se lf report on the survey 
and questionnaire.
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Lim itations
The limitations o f this study were:
1. The results o f this study depended on the participants’ accuracy 
and honesty in filling out the survey and questionnaire.
2. Distribution o f the survey and questionnaire was dependent on the 
facilitator. It is possible that not all support group members were 
asked to participate
3. Response was lim ited to the voluntary action o f the participants 
filling out the survey and questionnaire and mailing it back in self- 
addressed stamped envelope.
Definition o f Term s
Autoimmune Disease: The im m une system m istakenly attacks itself, targeting
the cells, tissues, and organs o f a person's own body (Scleroderma
Research Foundation, 2001).
Facilitator: Any person who leads or serves a role in leading o r organizing the 
respective support group meetings.
Health Locus o f Control: “degree to  which individuals believe that their health 
is controlled by internal o r external factors” (W allston & W allston, 1981 ). 
Internal Locus o f Control: “belief that ones outcom e is directly the result o f 
ones behavior” (W allston &  W allston, 1981 ).
M ultidim ensional Health Locus o f  Control Survey (M HLC): A survey 
consisting o f eighteen statements used to identify locus of control in 
individuals with respect to health (W allston & Grady, 1988).
Narrative Response Questionnaire: A questionnaire developed by the 
researcher to identify an individual’s health actions.
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Scleroderma: “Scleroderma is a chronic, degenerative disorder that leads to 
vascular deterioration, tissue loss and the overproduction of 
collagen in the body’s connective tissue” (Scleroderma Research 
Foundation, 1999).
Support Group: Any group o f scleroderm a patients, under the guidance and 
direction o f the Scleroderma Foundation, who meet in person as a means 
o f discussing, dealing and coping w ith their disease.
Support Group Member: Any person clinically diagnosed with scleroderma 
who is attending a respective Scleroderm a Foundation support group.
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C H A P T E R  II  
Review  o f L ite ra tu re
There is a lack o f inform ation regarding scleroderma patients and their 
ability to cope with their disease. The purpose o f this study was to describe 
individuals’ approaches to coping with their illness as it relates to their health 
locus of control.
S cleroderm a
Scleroderma, or “hard skin” , is defined by the Scleroderm a Foundation as 
a “chronic, often progressive autoim m une disease in which the body’s immune 
system attacks its own tissues” . It is also defined as an individualized disease, in 
which the degree o f severity varies with each person (Scleroderm a Foundation, 
2000).
There are two primary forms o f scleroderma, localized and systemic. The 
localized form com monly occurs in children and affects m ainly the skin. The 
systemic form is the m ore frequent type and also the m ore severe type, in which 
internal organs are affected in addition to the skin (Scleroderma Foundation, 
2000). Therefore, depending on the type o f  scleroderma, and the person, the 
symptoms vary and m ay include thickening o f the skin, jo in t pain, stiffness, loss 
o f flexibility, fatigue, weakness, and discoloration o f the skin (Arthritis 
Foundation, 2002).
Scleroderma affects approxim ately 300,000 people in the United States. 
The common age of onset ranges from  30-50 with women approximately 4  times 
more likely to be affected than men. W ithin the past three decades, there has been 
an increase in incidence o f the disease (M alcame, 2002). In addition, scleroderma 
is more prevalent than m uscular dystrophy or m ultiple sclerosis (Scleroderma 
Society o f Canada, 2002).
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
Scleroderma and Diagnosis
Diagnosis o f scleroderma is difficult because the symptoms overlap with 
many other autoimmune diseases such as lupus and rheumatoid arthritis 
(Scleroderma Foundation, 2000). There is currently no one specific test to 
diagnose the disease. Diagnosis is determ ined as a result of several tests, 
depending on the severity o f the person’s symptoms. Tests performed include 
pulmonary function tests, nail-fold capillary test, blood tests, x-rays, and 
electrocardiograms. Further research is necessary to determine more accurate 
means o f diagnosing the disease and developing a specific test to diagnose 
scleroderma (Scleroderma Research Foundation, 2002).
Scleroderma and Treatm ent
As with the diagnosis, there is no single drug or treatment that is proven or 
accepted to be effective in treating scleroderm a (W asko & M edsger, 2000). 
Treatment requires involvement o f various specialists including rheum atologists, 
and dermatologists. In addition, treatm ent includes a com bination o f m edications 
individualized for the patient based on the extent of the disease. Therefore, 
further research is also needed in order to develop more accurate treatment 
options for scleroderma patients (Scleroderm a Research Foundation, 2002). 
Scleroderma and Cause
The fundamental cause o f scleroderm a is unknown, but researchers are 
identifying possible imm unological, environm ental and genetic com ponents 
(Scleroderma Research Foundation, 2002).
Studies have identified abnorm ally high rates o f scleroderma w ith specific 
geographical areas and certain toxic chem icals. South Boston, M assachusetts, 
Detroit and Northampton, M ichigan, N orth Carolina have all been identified with 
a high incidence rates o f the disease. Research is being conducted to identify
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possible environmental factors or chemicals that m ight be responsible for these 
abnormally high rates o f the disease in these areas. In addition, people who are 
highly exposed to specific chemicals such as silica dust and polyvinyl chloride 
may have a higher risk for developing scleroderma (Harvey et al., 1999).
The role o f genetics remains questionable with scleroderma. Several 
studies have shown that some people may have a genetic predisposition to 
scleroderma. However, it is rare for direct family members to contract the 
disease. There is current research in studying the genome-wide gene expression 
patterns to further identify what role genetics plays in the disease. Some research 
has indicated that a gene, or genes, may create a greater risk for the disease, 
particularly if  the person is exposed to an environmental trigger (Scleroderma 
Research Foundation, 2002).
There are several studies identifying biological characteristics com mon 
among scleroderma patients. One such aspect, is the accum ulation o f scar tissue, 
but it is not conclusive as to whether this was prevalent before or after the patients 
were diagnosed (Scleroderma Research Foundation, 2001). This area is currently 
being investigated to further identify these biological patterns present w ithin those 
with scleroderma.
Scleroderma and Psvchosocial Dim ension
In respect to research exploring the psychosocial dimensions o f the 
disease, there are m inim al studies. Past research includes the exploration o f 
disability aspects £ind psychological distress such as depression, regarding 
scleroderma patients.
A current study is being conducted to develop a psychosocial profile o f 
individuals w ith systemic sclerosis and their spouses and to identify medical and 
psychosocial predictors o f  both disability and psychosocial adjustment. Aspects 
that are being assessed in this study include disease severity and associated
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symptoms, psychosocial adjustment self esteem and coping. Other studies have 
been done on rheumatic disease as a whole. However, M alcam e states the need to 
conduct studies specifically with scleroderm a to identify whether the results can 
actually be generalized to pertain to all rheum atic diseases (M alcame, 2002).
Social Learning Theory
The Social Teaming Theory was developed by Julian Rotter in 1966. The 
theory states that through a leam ing process, individuals develop beliefs regarding 
certain outcomes. According to the theory, individuals’ behavior can be predicted 
from “a knowledge o f how they view the situation, their expectancies about their 
behavior, and how they value the outcom es that m ight occur as a result of their 
behavior in that situation” (Sanders &  Suis, 1982). Rotter stated that an 
individual who believes that certain outcom es are a result o f their own actions 
have an intem al locus of control. An intem al locus o f control is the belief that 
people are responsible for what happens to them  and the outcome is under their 
control (W instead-Fry et al, 1999). In contrast, those individuals who believe that 
certain outcomes are a result o f outside forces such as fate, luck or chance have an 
extem al locus o f control (Rotter, 1975). An extem al locus o f control is the belief 
that people do not have control over the outcome, and w hat happens is out o f  their 
control.
From this theory. Rotter developed a Locus o f Control construct to 
measure whether an individual has an intem al or extem al locus o f control. This 
became known as the Rotter I E  Scale and has been used extensively in all areas 
o f research (Sanders & Sul, 1982). The purpose o f the scale is to determine 
generally whether or not a person has a strong orientation towards either an 
intem al or extem al locus o f control (W allston, 1992).
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Health Locus o f  Control
The Rotter I E scale allows for general identification o f a  person’s locus o f 
control. However, the Rotter I-E Scale does not directly address locus o f  control 
related to one’s health or illness (Levenson, 1973). Therefore, W allston & 
W allston developed health-specific measures o f R otter’s scale to be used in 
studying health and illness (W allston & W allston, 1981). This new construct was 
called the Health Locus o f Control Scale (HLC). The purpose o f the HLC is to 
identify the degree to which individuals believe that their health is controlled by 
internal or extem al factors. The HLC is com prised of eleven statements, five 
directed towards intem al locus o f control, and six statements directed towards 
extem al locus o f control. Responses to statem ents are recorded using a Likert 
Scale ranging from 1 (strongly disagree) to 6 (strongly agree).
High scores on the HLC Scale indicate agreem ent with the six extem al 
statements. Statements include, “W hen I stay healthy I’m  just lucky." The 
individual responds to the statements based on the level they agree or disagree. A 
high score indicates a high orientation towards an extem al locus of control. This 
means that individuals are likely to believe that other factors such as fate, luck or 
chance control the outcome o f their health or illness. A  high score is considered 
any score above thirty four, the median. (Sanders & Sul, 1982).
Low scores on the HLC Scale indicate disagreem ent with the six extem al 
statem ents and agreement with the five intem al statem ents. Intemal statements 
include “I am  directly responsible for my health.” The individual responds to the 
statem ents based on the level they agree or disagree. A low  score indicates a high 
orientation towards an intem al locus o f  control. This m eans that the individual 
is likely to believe that they are responsible for the outcom e o f their health or 
illness (W allston, 1992). A low  score is considered any score below thirty four.
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the median. (Sanders & Sul, 1982).
M ultidim ensional Health Locus o f Control
The HLC Scale does not m easure the influence o f other people on one 's  
health or illness. Therefore, W allston and W allston expanded on the HLC to 
incorporate a powerful others category. This new construct is known as the 
Multidimensional Health Locus o f Control Scale (MHLC). This construct is 
comprised o f eighteen questions with three categories. Each category contains six 
belief statements, for a total o f  eighteen statem ents to make up the M HLC. The 
categories include Intemal Health Locus o f  Control (IHLC), Chance Health Locus 
of Control (CHLC), and Powerful O thers Locus o f Control (POLC) (W allston and 
W allston, 1976).
The Intemal Health Locus o f  Control Scale (IHLC) measures the degree to 
which individuals believe they are responsible for their health and the outcome is 
under their control (W instead-Fry et al, 1999). The six belief statements in this 
category identify peoples’ beliefs that they are responsible for their illness. This 
category consists o f statements such as “I am  directly responsible for my condition 
getting better or worse” . The individual rates each statement using the same six- 
point Likert scale ranging from 1 (strongly disagree) to 6 (strongly agree) that was 
developed with the HLC.
The Chance Health Locus o f Control (CHLC) measures the degree to 
which individuals believe that their health is controlled by extemal factors such 
as fate, luck or chance (W instead-Fry et al, 1999). The six statements in this 
category identify the degree to which people believe that extem al variables are 
responsible for their illness. This category includes statements such as “M ost 
things that affect my condition happen to m e by chance” . The individual rates 
each statement using the same six point L ikert scale ranging from 1 (strongly 
disagree) to 6 (strongly agree).
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The POLC has two subcategories, other people and doctors. The two 
subcategories consist of three belief statements each to m ake up six statem ents for 
the POLC. The other people subcategory measures the degree to which 
individuals believe people such as family or friends are responsible for their 
health. This category consists o f statements such as “The type o f help I receive 
from other people determines how soon my condition im proves” . The doctor 
subcategory measures the degree to which individuals believe their doctor is 
responsible for their health. This category includes statem ents such as “If I see 
my doctor regularly, I am less likely to have problems with my condition”. Both 
subcategories are also answered using the six point Likert scale ranging from 
1 (strongly disagree) to 6 (strongly agree) (Sanders & Sul, 1982).
Locus o f  Control Research Findings
Previous research has found that a high intem al locus o f control is 
associated with an increased likelihood of healthier behaviors and actions (Lau, 
1988). These behaviors include exercise, lim iting fat intake, not smoking, dental 
care and sodium intake (Steptoe & W ardle, 2001). In addition, it was found that 
an intemal locus o f control is associated with a greater sense o f psychological and 
physical well-being (Gfellner & Finlayson, 1988, Goldsm ith et al, 1988). Several 
researchers have identified individuals who have high internal locus o f control are 
more active in seeking inform ation regarding their illness. Seeman and Evans 
(1962) studied tuberculosis patients and found that those w ith high intem al locus 
o f control knew more about their condition and questioned doctors and nursed 
more, regarding their condition, than those with low intem al scores.
One study found that an internal health locus o f control orientations was 
related to successful self-care practices at a  general health center in London 
(McLean and Pietroni, 1990). In another study, researchers interviewed m ultiple 
sclerosis patients and identified that those with intem al health locus o f control
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orientation had greater knowledge o f their disease. Furthermore, they practiced 
more self-care behaviors than those w ith an extem al health locus o f control 
(Wassem, 1991).
Changeability of Intem al Score
Several researchers within the academic setting identified the ability to 
change a person’s locus o f control, once it is known. One researcher found that 
college students who were engaged in a type o f therapy em phasizing personal 
freedom and responsibility becam e more intem al on the Rotter’s locus o f control 
scale. In another study, the researchers offered short-term therapy to college 
students to eliminate self-defeating behaviors. They re-tested the students, and 
their locus o f control scores becam e m ore internal (Lefcourt, 1982).
Although m ost of the research pertaining to change involves the locus of 
control within academic settings, as identified with the attribution theory, these 
findings are significant. This inform ation should be tested within the health 
setting with the health locus of control to identify if  similar results occur.
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CHAPTER III 
M ethodology
There is a lack o f inform ation regarding scleroderma patients and their 
ability to cope with their disease. The purpose o f this study was to describe 
individuals’ approaches to coping with their illness as it relates to their health 
locus o f control.
Sam ple Selection
The target population for this study was scleroderma patients attending 
support groups associated w ith the Scleroderma Foundation. To ensure regional 
diversity, eight support groups were contacted through an initial email. The 
support group inform ation was listed on the Scleroderma Foundation W ebsite 
(www.scleroderma.org) and included em ail contact inform ation for each support 
group. The support groups were selected based on geographical location to allow 
for representation o f various regions within the United States. The selection 
process was also based on the support groups that listed their email contact 
information for their individual office and chapter on the website.
The support groups initially contacted included Arizona, Florida, 
M ichigan, M innesota, New England Chapter, Nevada, Oregon, and Texas. The 
New England Chapter consisted o f five states which include Maine, 
M assachusetts, New Hampshire, Rhode Island and Vermont. The em ail 
consisted o f a brief introduction about the research and asked if  the respective 
support group was interested in participating in the study. A  reply to the em ail 
was requested. Six o f the support groups replied and agreed to participate in the 
study. The participating support groups included Florida, M ichigan, M innesota, 
Nevada, Oregon and Texas.
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Instrum entation
The study utilized both quantitative and qualitative methods. The two 
instruments used in this study were the M ultidimensional Health Locus o f Control 
Survey (MHLC) and the Narrative Response Questionnaire (NRQ). The M HLC 
is a quantitative m ethod and provided scores to identify low versus high intem al 
health locus o f control. The NRQ is a qualitative measure developed by the 
researcher. The questionnaire consisted o f questions about individuals’ 
perceptions and actions towards their illness. A demographic page accompanied 
these two instruments.
Survev
The M ultidimensional Health Locus o f Control Survey (MHLC) was 
developed to measure a person’s locus o f control in respect to their health (see 
Appendix) (W allston et al., 1978). The M HLC was com prised o f three categories. 
Each category contained six belief statem ents, for a total o f  eighteen statements to 
make up the MHLC. The categories included Intem al Health Locus o f Control 
(IHLC), Chance Health Locus o f Control (CHLC), and Powerful Others Locus o f 
Control (POLC) (see Appendix A).
Category I, the Intemal Health Locus o f Control (IHLC), measured the 
degree to which individuals believe they are responsible for their health and their 
health outcomes are under their control (W instead-Fry et al, 1999). This 
category consisted o f statements such as “I am directly responsible for my 
condition getting better or worse” . The participant rated each statement using a 
six-point Likert scale ranging from 1 (strongly disagree) to 6 (strongly agree).
Category H, the Chance H ealth Locus o f Control (CHLC), measured the 
degree to which individuals believed that their health was controlled by extem al 
factors such as fate, luck or chance (W instead-Fry et al, 1999). This category
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included statements such as “M ost things that affect my condition happen to me 
by chance” . The participant rated each statem ent using the same six point Likert 
scale ranging from 1 (strongly disagree) to 6 (strongly agree).
Category m , the Powerful O ther Health Locus o f Control (POLC), had 
two subcategories, other people and doctors. The two subcategories consisted o f 
three belief statements each to make up six statements for the POLC. The other 
people subcategory measured the degree to which individuals believed people 
such as family or friends are responsible for their health. This category consisted 
of statements such as “The type o f help I receive from other people determines 
how soon my condition im proves” . The doctor subcategory m easured the degree 
to which individuals believed their doctor was responsible for their health 
(Sanders & Suis, 1982). This category included statements such as “If I see my 
doctor regularly, I am  less likely to have problem s with my condition”. Both 
subcategories were also answered using the six point Likert scale ranging from 
1 (strongly disagree) to 6 (strongly agree).
For the purpose o f this study, the main focus was on the IHLC. Previous 
researchers have found that a high intem al locus o f control is associated with an 
increased likelihood o f healthier behaviors and actions. These behaviors include 
exercise and limiting fat and sodium intake (Steptoe & W ardle, 2001). In 
addition, research has related a high intem al locus o f control w ith behaviors that 
include being more actively involved in one’s health and health care. It has been 
determ ined that individuals w ith a high intem al locus o f control experience 
greater psychological and physiological benefits than those with low intem al locus 
o f  control (W allston & W allston, 1982). Therefore, participants in this study were 
exam ined from the perspective o f their orientation toward IHLC.
The POLC and CHLC categories were not em phasized in this study. 
However, individuals’ scores for the CHLC and POLC were identified and
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described.
Reviews o f previous studies provided evidence o f survey reliability and 
validity (W allston & W allston, 1981, 1982). There is validity for the use o f  locus 
of control in research on individuals in regard to health behaviors. Researchers in 
one study identified a strong relationship between health beliefs, health locus o f 
control and w om en’s mammography behavior. They m easured alpha reliabilities 
that indicated internal consistency o f the M HLC that ranged from 0.673 to 0.767. 
Furthermore, a test o f predictive validity found that the health status correlated 
positively with internal health locus o f control (r=0.403, p<0.01) (Holm, Frank & 
Curtin, 1999). In another study, researchers identified a relationship between 
health behaviors such as smoking and diet and locus o f control. They received 
similar alpha reliabilities for the M HLC scale as the previous study. They further 
identified a strong relationship between positive health behavior and internal 
health locus o f control (W allston et al., 1978). The M HLC Scales have been used 
extensively in health research and are shown to have adequate internal consistency 
(Fum ham  & Steele, 1993).
MHLC Scoring
There is a scoring sheet detailing w hich questions on the survey belong in 
each category. The num ber the person selects is based on a range o f 1 to 6 for 
each question. Each category is scored independently. A  high score in one 
category is not indicative o f a low score for a separate category. For exam ple, a 
high CHLC score does not indicate that the IHLC score will be low. It is possible 
to have a high score in more than one category or a low  score in more than one 
category. The CHLC and IHLC both have a m axim um  score o f 36. A higher 
score in a category indicates a stronger orientation toward that dimension. For 
example, a score o f 30 in the CHLC category indicates a high external locus o f 
control belief towards one 's illness. W hereas, a  score o f 10 in the CHLC category
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would indicate a low external locus o f  control belief towards one’s illness.
The POLC has two subcategories, other people and doctors. The two 
subcategories consist of three questions each to make up six questions for the 
POLC. Therefore, there is a possible m axim um  score o f  18 for each o f the two 
subcategories. If individuals have a score o f 15 in the other people subcategory, 
that identifies a high belief that other people are responsible for their health. 
However, if  they have a score o f 5 in the other people category that identifies a 
low belief that other people are responsible for their health.
Questionnaire
The Narrative Response Questionnaire (NRQ) was developed by the 
researcher for the purpose o f identifying coping behaviors and perceptions o f the 
participants in regard to their disease. Sim ilar questions were asked in studies 
using Attribution Theory. The questions in these previous studies were designed 
to explore the component o f Attribution Theory that relates to internal locus of 
control. In addition. The NRQ questions were developed based on a review o f the 
literature of the Health Locus o f Control. The HLC has been shown to influence 
individuals’ perception o f the cause of their disease, how their disease has affected 
their lives, and what actions they are taking to cope with their disease. Thus, 
questions on the NRQ were designed to illicit information in these areas.
The Narrative Response Q uestionnaire is comprised o f three questions.
The individual was instructed to answer each question using the provided space. 
The length of response to each question was dependent upon the individual. In 
addition, content and thoroughness o f  the answers were also dependent on the 
individual.
The first question asked participants to explain what they believe caused 
their scleroderma. The second question asked how scleroderm a has affected their 
personal life in respect to family and work. The third question asked participants
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to State what actions they were taking to cope with scleroderma. Examples were 
listed to give participants an idea o f the o f responses pertinent to the question. 
Demographic Page
A demographic page was also included for the participant to complete.
The instructions stated that responding to each part o f the study is voluntary, 
including the demographic page. Participants were asked for inform ation about 
their age, gender, location, ethnicity, level o f education, date o f diagnosis with 
scleroderma, length of support group attendance, and various types o f health 
professionals with who they are regularly seeing. They were also asked to rate 
their health status from  1 (excellent) to 4 (poor).
Data Collection
After approval from the University o f M ontana Institutional Review 
Board, the surveys and questionnaires were sent to the support groups’ main 
offices. The support group facilitators agreed to distribute them  to the support 
group members. Each facilitator received a package consisting o f a cover letter, 
an instruction page and individual packets for distribution to the participants (see 
Appendix D & E). The cover letter included background information about the 
researcher and the study. The instructions explained the facilitators’ role and 
involvement in the study. The facilitator’s m ain role was distribution o f the 
enclosed individual packets. The distribution format was left to the facilitator’s 
best judgm ent and varied with each support group. Approximately two weeks 
following packet distribution, the facilitator was asked to send out a general 
message to the members. This message served as a reminder for the members to 
send in their com pleted packets to the researcher, and it was dependent upon the 
facilitator’s ability to contact members through a group em ail or phone message. 
This was left up to the facilitator. After this general reminder, the facilitator’s role 
in the study was com plete.
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The individual packets included a cover letter to the individual support 
group m em ber (see Appendix D). The cover letter included background 
information on the researcher and the study. The letter was accompanied by a 
page o f instructions detailing the participant’s role in the study (see Appendix E). 
The participants were asked to fill out the survey, questionnaire and dem ographic 
page and place them  in the enclosed self-addressed stam ped envelope and mail it 
back to the researcher. Participation was voluntary. No names were listed on any 
o f the material that was sent back to the researcher. This ensured confidentiality. 
After the participant m ailed the inform ation back to the researcher, the 
participant’s role in the study was complete.
Data Analysis
Responses for each category on the MHLC were scored using a six-point 
Likert scale ranging from  1 (strongly disagree) to 6 (strongly agree). Scores were 
calculated for each category resulting in a health locus o f control profile for each 
participant. Descriptive statistics were used to provide a summ ary o f overall 
group results.
Participants were sorted into the two groups. High ILOC and Low ILOC. 
The High ILOC group consisted o f those who scored above the median o f 18, on 
the internal locus o f control subscale. The Low ILOC group consisted o f those 
who score below the m edian o f 18, on the internal locus of control subscale.
The NRQ was used to describe participants’ approaches to coping with 
their illness. This was accom plished through qualitative analysis of the NRQ. The 
responses to the NRQ were reviewed and divided into two groups. Responses of 
those individuals w ho scored high on the ILOC were analyzed separately from  
those who scored low. Them es or similar thoughts were identified, and described. 
The demographic page was analyzed descriptively. The SPSS program was used 
to obtain percentages for each response.
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CH APTER IV  
Results 
Packet Returns
A  total o f 100 packets containing the HLOC survey, NRQ and 
demographic page, were sent to 6 support groups. The distribution num ber was 
based on the group facilitators’ estim ation o f their support group size. The 
distribution was com prised of 10 for Nevada, 15 for Oregon, 10 for M ichigan, 30 
for M innesota, 20 for Florida, and 15 for Texas. Thirty-two packets were 
returned, from  3 o f the support groups. M ichigan returned 7, Nevada returned 3 
and 22 were returned from M innesota.
Dem ographics
Participants’ Gender
Female (n=30) 93.8%
M ale (n= 2) 6.2%
Age
40-49 (n=5) 15.6%
50-59 (n=13) 40.6%
60-69 (n = ll )  34.5%
70-79 (n=3) 9.3%
M arital Status
M arried (n=19) 59.4%
Single (n=12) 37.5%
Significant Other (n= 1 ) 3.1%
Race/Ethnicitv
Caucasian (n=29) 90.6%
Native American (n=2) 6.3%
Hispanic/Latino (n = l) 3.1%
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Educational Level
High School (n=4) 12.5%
Associate Degree (n=5) 15.6%
Vocational/Technical (n = l) 3.1%
Some College (n=13) 37.5%
College/Degree (n=6) 18.8%
Professional/Graduate (n=3) 9.4%
Length of Diagnosis
0-5 years (n=10) 31.2%
6-10 years (n= 16) 50.0%
11-15 years (n=6) 18.7%
Tvpe o f Scleroderma
Localized (n=4) 12.5%
Systemic (n=27) 84.4%
N ot Sure (n = l) 3.1%
Support Group Participation
0-5 years (n=21) 65.7 %
6-10 years (n=10) 31.3 %
11-15 years (n= l) 3.1%
Tvne o f Health Professionals Sought
Rheumatologist (n=29) 90.6%
Dentist (n=25) 78.1%
Cardiologist (n=16) 50.0%
Opthamologist (n=14) 43.8%
Internist (n=13) 37.5%
Other (n=9) 28.1%
Pulmonologist (n=8) 25.0%
Nutritionist/Dietician (n=5) 15.6%
Dermatologist (n=5) 15.6%
Physical Therapist (n=4) 12.5%
Naturopathic (n = l) 3.1%
Herbalist/Alternative (n = l) 3.1%
Psychologist (n = l) 3.1%
Health Status
Excellent (n=3) 9.4%
Good (n=18) 56.3%
Fair (n=9) 28.1%
Poor (n=2) 6.3 %
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
2 3
The perception o f health status appeared to have somewhat o f a pattern 
between the High-ILOC and the Low-ILOC groups. The two participants who 
rated their health as poor were both in the Low-ILOC Group. In addition, all three 
participants who rated their health as excellent were in the High ILOC Group.
This could indicate a pattern between excellent health status with High ILOC and 
poor health status perception with Low ILOC. The remaining responses were 
distributed between the good and fair selections between the two groups.
The length o f tim e in a support group and length o f diagnosis appeared to 
have no relationship between the H igh ILOC and the Low ILOC groups. 
Participants’ responses from both groups were distributed among the three 
selections for length o f diagnosis. However, for the length o f time in a support 
group, the two groups were distributed evenly among the first two selections. The 
last option, 11-15 years had only one response, which was from a participant in 
the High ILOC Group.
M H LC Survey
The surveys were scored using the standard score sheet. O f the 32 
returned, 26 individuals scored high for internal locus o f control (High ILOC, 18 
or higher), and six scored low on internal locus o f control (Low ILOC, less than 
18). Each participant’s scores on all subscales of the HLOC are reported in Table 
1 below.
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T ab le  1: H ealth  L ocus o f  C o n tro l Score Profiles
HLOC SUBSC A LE SCORES
Parti Internal . External  ̂ Powerful Others '
cipa ... , (B u tors»  O ther People)
nt ■ . ' ' '
#  1 High (22) Low (11) High (19 - 1 1 , 8 )
# 2 High (19) Low (17) High (19 - 1 2 , 7 )
# 3 High (21) Low (15) High (23 - 10,13)
# 4 High (20) Low ( 9 ) High (22 - 12,10)
# 5 High (21) Low ( 9 ) High (27 - 11,16)
# 6 High (32) Low ( 7 ) High (21 - 1 6 . 5 )
# 7 High (30) Low (16) High (22 - 1 7 , 5 )
# 8 High (19) High (19) High (25 - 14,11)
# 9 High (19) Low ( 9 ) High (20 - 1 3 , 7 )
#10 High (19) Low ( 9 ) High (26 - 14,12)
#11 High (23) Low ( 6 ) High (23 - 1 6 , 7 )
#12 High (19) Low (17) High (19 - 1 2 , 7 )
#13 High (21) Low (15) High (23 - 10,13)
#14 High (19) Low (17) High (19 - 1 2 , 7 )
#15 High (23) Low ( 6 ) High (23 - 1 6 , 7 )
#16 High (21) Low ( 9 ) High (27 - 11,16)
#17 High (23) Low ( 6 ) High (23 - 1 6 , 7 )
#18 High (21) Low (15) High (23 - 10, 13)
#19 High (21) Low ( 9 ) High (27 - 11,16)
#20 High (19) Low ( 9 ) High (26 - 14,12)
#21 High (23) Low (14) High (20 - 12, 8 )
#22 High (21) Low ( 9 ) High (27 - 11,16)
#23 High (19) High (20) High (24 - 1 6 , 8 )
#24 High (20) Low ( 15 ) High ( 19 - 14,5 )
#25 High (20) Low ( 17 ) High (2 2  - 13, 9 )
#26 High (19) Low ( 1 1 ) High ( 20 - 9, 11 )
#27 Low (13 ) Low ( 12 ) Low (1 5  - 9, 6 )
#28 Low ( 6 ) H igh (23) Low (1 1  - 8, 3 )
#29 Low ( 9 ) Low (15) Low ( 8  - 5, 3 )
#30 Low ( 9 ) Low (17) Low ( 9  - 6, 3 )
#31 Low (11) Low (13) Low (13 - 9, 4 )
#32 Low (10) Low (12) High (19 - 16,3)
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The distribution o f HLOC subscale scores are further illustrated in charts 1 
and 2 below. Chart 1 shows the subscale scores o f participants with high internal 
locus of control, while chart 2 shows the subscale scores of participants w ith low 
internal locus of control.
Chart 1: Subscale Scores for Participants with High Internal Locus o f  
Control
Subscale Scores
Ô 20
1 3 5 7 9 11 13 15 17 19 21 23 25
Participants
• Internal Subscale
External Subscale
Powerful Others 
Subscale
For individuals with High Internal Locus o f  Control, mean scores and standard 
deviations for each subscale are as follows:
Internal subscale m  = 21.3 SD = .62
External subscale m  = 10.8 SD = .92
Powerful Others subscale m  = 22.6 SD = .55
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Chart 2: Subscale Scores for Individuals with Low Internal Locus o f  
Control
Subscale Scores
25
«  20
S> 15
8 10 
t/)
Internal Subscale
External Subscale
- -  • Powerful Others 
Subscale
Participants
For individuals with Low Internal Locus o f  Control, mean scores and standard
deviations for each subscale are as follows:
Internal subscale m — 9.6 SD = .95
External subscale m  = 15.3 SD — 1.7
Powerful Others subscale m = 12.5 SD = 1.6
Narrative Response Questionnaire
Com mon themes arising from each question on the N RQ  are described below. 
Com monalities among individuals who scored high on the Internal Locus of 
Control Sub-scale (n= 26) are described first, followed by a description o f 
commonalities for individuals who scored low on the Internal Locus o f Control 
Sub-scale (n=6).
High Internal
Question 1: P lease explain what you  believe caused yo u r scleroderma.
Theme #1: Stress
Stress, participants stated, caused their im m une systems to become 
com prom ised and thus more vulnerable and susceptible to diseases, such as 
scleroderma.
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Responses included:
“Stress, stress stress. I  truly believe it had a m ajor impact on the onset o f  
Scleroderma  ”
“Stress, I  think my jo b  was a big “trigger" and wore down my immune 
system "
“I  believe that stress had a huge impact on my disease, I  had many fam ily  
situations, deaths, in a short period  o f  time and that was hard on m e"
Theme #2: Genes/Hereditv
Nearly half o f  the participants in the high internal locus o f control category
stated genes and or heredity played a factor in causing their disease. None of the
participants described family m em bers with scleroderma, but several reported
other auto-inunune diseases, such as arthritis and m ultiple sclerosis that run in
their families.
Responses included:
“I  think it is in the genes, I  think my fa m ily  history o f  autoimmune 
diseases and there could be a gene m aking me more susceptible to 
scleroderma "
“I  believe it was largely heredity. Arthritis runs in my fa m ily"
“I  believe my case o f  scleroderma is due to a genetic predisposition to the 
disease "
Theme #3: Environmental Triggers
A few o f the participants in the high internal locus o f control group 
described environmental factors they believe contributed to causing their 
scleroderma. The factors included exposure to toxic fum es or viruses in the 
environment. The participants believed this exposure weakened their immune 
system, allowing for them to becom e susceptible to disease.
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Responses included:
"environmental triggers, pa in ted  house and fum es were unbearable and  
caused me to fe e l sick”
"After reading some opinions on the disease, I  think there may have been 
"triggers " which created the onset. The summer before diagnosis. I  
painted  the exterior o f  the house, using silicone caulk, latex paint, oil 
based pain t and turpentine ”
"One thought- I  refinished a desk, couldn  7 apply fin a l fin ish  because o f  
severe headache fro m  the fu m e s ”
Question 2: How has Scleroderm a affected yo u r life?
T h em e# !: Physical Limitations
The most common answers to this question were centered around physical 
lim itations associated with scleroderma. Some o f the lim itations mentioned 
were fatigue, lack o f mobility and sensitivity to cold. In addition, many 
participants stated they had to rely on supportive family members to assist them 
with many tasks, such as household chores because o f these limitations. 
Responses included:
" I ’m overly concerned about weather and ways to dress, to keep warm  
and comfortable ”
"M y fam ily  helps me with chores and  daily tasks ”
"I lost stamina and initially had jo in t pain, I  lost mobility "
"Poor sleep with reflux problem s ”
Them e #2: W ork/ Job Related Changes
Several participants stated that their ability to w ork was affected by 
scleroderma. Several participants stated they had to m ake changes such as 
decreasing their work hours, taking a tem porary break from  their job , or stopping 
work altogether.
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
2 9
Responses included:
" /  often m issed work and eventually took advantage o f  an early 
retirement proposal "
“I  can only work 20 hours a week ”
“I  switched to working in the office 2 or 3 hours a day instead”
Theme #3: Effect on Recreational Activities
Participants also stated they had to lim it or elim inate recreational activities 
because o f their physical lim itations. Theses recreational activities included 
sports and personal interests/hobbies.
Responses included:
“No longer able to do crafts and hobbies "
“/  can no longer do some physical activities I  once d id  such as snow  
skiing, tennis, g o lf and bow ling”
“I  can ’t sing in the choir because o f  gastroesophageal dijficulty. "
“I  used to love to sail, but have curtailed that because it is too much work 
on me n o w ”.
Question 3: P lease describe in as m uch detail as possible, the actions you  are  
currently taking to cope with yo u r illness.
Theme #1: Social Actions
All of the participants m entioned the im portance o f social interactions
through participating and belonging to a support group. The participants also
com m ented on having a network o f friends and family in addition to their support
group. Some o f the responses included:
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“We have a close knit support group and call each other often to hash over 
symptoms and remedies ”
‘7  belong to a support group which is the best thing I  could have done. I  
am  also blessed with a wonderful support system o f  fa m ily  and fr ie n d s”
“M y support group has really helped and my friends and fam ily  keep my  
spirits up "
Theme #2: Physical Actions
Participants described a variety of physical actions they are taking to
alleviate their scleroderma symptoms. These physical actions included exercise,
improving eating habits, getting enough rest, and taking medications. Some o f the
responses included:
“I  try to walk or exercise regularly and eat lots o f  veggies and fru it and  
get plenty o f  re s t”
‘7  jo ined  an exercise program  and go with a fr ien d  3-5 times a week fo r  
an hour, I  also take a multi-vitamin and try to eat better”
“Pacing activities to preserve energy, allowing fo r  nine hours o f  sleep per  
n ig h t”
“I  have used and enjoyed paraffin  baths fo r  my fingers ”
“/  take my medications daily and keep close contact with m y doctors ”
“I  get proper hours o f  sleep and take prescriptions and massage m y  
fingers and hands ”
Theme #3: M ental Actions
About half o f the participants com m ented that they research and read
inform ation regarding their disease. M any com m ented on the im portance o f
keeping up to date on the latest inform ation regarding their illness. Some o f the
responses included:
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*‘read a lot and research on the in ternet”
“I  try to keep current on status o f  research about scleroderma through 
publications, books, and on-line web sites "
“I  read anything new about scleroderma ”
Theme #4: Spiritual/Religious A ctions
Several participants stated that they engage in spiritual or religious 
activities such as meditating, praying or attending church. The participants stated 
that their religious beliefs are an im portant action they take to cope with their 
disease. In addition, many participants included actions they take to increase their 
spirituality, such as meditation. Some o f the responses included:
‘‘prayer is an im portant p a rt o f  my life. ”
“ We pray a lo t fo r  each other, I  believe in prayer very strongly ”
" / go to church and pray a lo t”
“/  meditate fo r  m y spirituality and overall well being ”
‘‘Meditating and p ra yer”
L.OW Internal
This category consisted o f only six participants m aking it difficult to 
identify themes for each question. Therefore, all six o f the participants’ responses 
for each question are described.
Question 1: Please explain what you  believe caused you r scleroderma.
M ost o f the participants stated the cause o f their scleroderma was due to 
either stress or heredity. Two stated they were not sure what caused their disease. 
The responses included:
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" /  am inclined to believe that there was something in m y genetics that 
malfunctioned. ”
“Perhaps a gene is present in scleroderma patients and stress starts the 
disease. ’’
“unknown, probably a genetic predisposition  ”
“I  have no idea ”
“I  have no idea w hat caused me to get scleroderma, my doctor doesn ’t 
know either”
“I  really fe e l the stress in m y life took its to ll”
Question 2: H ow has Scleroderm a affected yo u r life?
The responses for this group were physical lim itations, work, and 
recreational limits. A ll o f  the responses are listed below.
“It has caused me to lose m y job , due to fa tigue and pain. M y husband is 
real good about trying to understand. ”
*‘F or a time /  could not work long hours ”
“Feeling good enough to take trips have come to a ha lt"
“/  try to be as active as I  can but interest in things I  once enjoyed has 
w aned”
“It is hard to write and type ”
“It has caused me to lose m y jo b  due to the fa tigue and pain. ”
Question J.* Please describe in as much detail as possible, the actions you  are  
currently taking to cope with you r illness.
The actions listed for this question were prayer, nutrition, exercise and
support group attendance. Some o f the responses included:
“I  attend a support group, w alk and read. ”
“I  really fe e l  it is important to keep active with m y support group ”
“ I  p ra y  daily ”
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“I  attend church to enhance m y spirituality  "
"Try and exercise and stay fle x ib le”
“/  began to eat more nutritiously, adding more fru its  and vegetables'
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CHAPTER V  
Summary o f Findings
The purpose o f  this study was to describe individuals’ approaches to 
coping with their illness as it relates to their health locus o f control.
Participants were all scleroderma patients and members of support groups 
affiliated w ith the Scleroderma Foundation. The researcher contacted six o f these 
support groups through the Scleroderma Foundation Support Group Listing. 
Group facilitators agreed to approach their members with the information packets 
sent by the researcher. Information packets contained instructions and 
inform ation regarding the researcher, the M ulti dimensional Health Locus of 
Control Survey (MHLC survey), the Narrative Response Questionnaire (NRQ) 
and the dem ographic page.
Out o f  one hundred packets sent to six support groups, thirty two were 
returned, resulting in a 32 percent return rate. Twenty-six of those returning the 
packets fell into the high internal locus o f control group (High-ILOC Group), 
while only six fell into the low intem al locus o f control group (Low-ILOC 
Group). Because o f the uneven distribution o f participants between the two 
groups, only limited comparisons and contrasts could be made between the High- 
ILOC Group and the Low-ILOC Group.
Dem ographics
The majority o f the participants (93.8%) were women. Participants’ ages 
ranged from  40 to 77. These demographics are somewhat congruent with those
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found in the literature where women are four times as likely as men to be affected 
by scleroderma and the typical age range for scleroderma patients is between 30 
and 50 years (M alcame, 2002). M ost o f the participants were Caucasian (90.6%), 
m arried (59.4%), and had at least some college (65.7%).
Other information from the demographic page indicated that the m ajority 
o f participants had been diagnosed for more than 6 years (68.7%), participated in 
a support group for less than 6 years (65.7%), and were diagnosed with the 
systemic form o f scleroderma (84.4%). In addition, the majority o f participants 
were seeing a rheumatologist (90.6% ) and/or a dentist (78.1%) as their main 
health care professionals. O ther health care professionals sought out by 
participants included: cardiologist (50%), optham ologist (43.8%), internist 
(37.5%), other (28.1%), pulm onologist (25%), nutritionist (15.6%), dermatologist 
(15.6%), physical therapist (12.5%), naturopathic (3.1%), herbalist (3.1%) and 
psychologist (3.1%). It was surprising that m ore participants were not seeing 
internists, since previous literature has indicated that they are also considered a 
prim ary health care professional for scleroderm a treatm ent along with 
rheumatologists (Scleroderma Foundation, 2000).
The responses for health status indicated som ewhat o f a pattern related to 
ILOC. All o f the participants w ho perceived their health as poor were in the Low 
ILOC Group(n=2) and all o f the participants who perceived their health as 
excellent were in the High ILOC Group (n=3). The rem aining responses for each 
group were distributed between the good and fair selections. The length o f 
diagnosis and length o f participation in a support group did not indicate a pattern
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related to ILOC. However, the only person who had participated in a support 
group for more than 10 years was in the High ILOC Group.
Discussion o f Hi^h TT.OC Group
As was expected, the m ajority o f participants who scored high on the 
intemal subscale (High BLOC Group) scored low on the external subscale on the 
M ultidimensional Health Locus o f Control survey (MHLC). The low score for the 
external subscale indicates that these participants do not believe that 
environmental factors control their health. A lthough some participants felt there 
were environmental or outside triggers involved in the onset of their disease, they 
stated on the NRQ that these factors did not control their health. W hen they were 
asked to write about the actions they were taking to cope with their illness, the 
majority o f participants in this group listed num erous behaviors they were actively 
engaging in to take control o f and responsibility for their health. This is consistent 
with the literature that describes high internals as more likely to engage in healthy 
behaviors and strive for physical well being (W allston, 1976).
All of the participants in the High ILOC Group also scored high on the 
powerful others subscale on the M HLC. The powerful others subscale is divided 
into two categories, doctors and other people. A  high score in either category 
indicates that individuals strongly believe that doctors or other people m aintain 
control of their health. In this study, participants’ scores indicated that they 
relied more heavily on doctors than they did on other people. And w hile a high 
score in the “doctors” category indicates that participants feel that doctors have 
control over their health (M alcame, 2(X)2), another interpretation o f the m eaning
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of these scores may be reasonable. As previously stated, the literature shows that 
high internals are likely to strive for physical well being. In addition, past 
research has also shown that those w ith high internal locus o f control are more 
likely to seek information regarding their condition (M alcame, 2002). Thus, 
individuals with high intem al locus o f control m ight view powerful others, 
especially doctors, as a source o f inform ation as indicated by several people’s 
responses. One participant stated, “I always ask my doctor for updates on new 
medications and treatm ents” . Furtherm ore, they m ay view the gathering o f that 
information as an im portant step in their quest to gain additional control over the 
course o f their illness. This interpretation is supported by information from the 
NRQ where participants stated the im portance o f researching new information on 
scleroderma. Seeking inform ation from  doctors may be seen by High ILOC 
individuals as a means o f  conducting research on their illness.
A  close connection between the powerful others and internal subscale also 
is illustrated in participants’ responses to the second question on the NRQ. This 
question asks individuals to explain how scleroderm a has affected their lives. It 
was interesting to note that the H igh ILOC participants stated that their lives had 
been affected in such a way that it was necessary for them  to rely more heavily on 
others for support. This could further explain the high powerful others score 
among the High BLOC group. Reaching out to other people may possibly be 
another action they engage in to cope with and maintain control over their disease. 
High ILOC Profile
Analysis o f data from  this study indicates that participants with high
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intem al locus o f control displayed several characteristics. First, they scored high 
in both the intem al and powerful others subscales. They perceived powerful 
others, especially doctors, as sources o f inform ation and as a means of 
maintaining control o f their health. Furtherm ore, they relied extensively on 
friends and family as a means o f support and assistance in coping with their 
scleroderma. Finally, persons with high ILOC were able to describe a variety o f 
actions that they were taking to cope with their illness and had a generally positive 
outlook towards their illness.
Discussion o f Low ILOC Group
The following description should be interpreted with caution because o f 
the minimal num ber o f participants who fell into the Low ILOC category. 
Furthermore, inform ation gathered from analysis of responses on the N R Q  cannot 
be generalized to other individuals with scleroderma.
M ost o f the participants in this category scored low in all three subscales, 
intemal, extem al and powerful others. It was surprising that the majority o f  
individuals in the Low-ILOC group also scored low for both the extem al and 
powerful others subscales. It would seem reasonable that if  individuals do not 
believe they have personal control over their health, they would believe either the 
environm ent or powerful others would have control. However, this was not the 
case. The majority o f the Low BLOC group did not believe that they or any other 
identifiable source controlled their health. In fact, two o f the participants stated 
on the NRQ that they did not know what caused their illness.
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The responses o f the Low-ILOC group to questions on the NRQ were 
somewhat ambiguous and were not written in as m uch detail as were the 
responses o f  the High ILOC group. For exam ple, this group listed only a few 
actions they take to cope with their illness. There was no mention o f seeking 
information or taking active responsibility in researching information on their 
illness. Furtherm ore, there was no m ention o f outreach to others, such as family 
or friends. There was a sense of isolation among this group, in regards to their 
illness and relationships to others. There was a tone of feeling alone and not 
being able to obtain support or help from  loved ones.
I ow IT XyC Profile
Overall, analysis o f data from  this study indicates that a person w ith low 
intem al locus o f control would tend to display several characteristics. First, they 
scored low on all three subscales. Participants do not feel able to reach out to 
others for support or reassurance. Furtherm ore, they listed only a few actions they 
are taking to cope w ith their illness, and the actions did not directly relate to 
actively taking responsibility in controlling their illness and acquiring new 
information. Overall, they were unable to give detailed explanations o f factors 
regarding their health, and they viewed their illness as a mystery they are unable to 
solve. Their outlook toward their illness was not as positive as those with a high 
intem al locus of control.
Lim itations o f  the Study
Results from this study apply only to those individuals who participated in 
the study and should not be generalized to all individuals who are afflicted w ith
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scleroderma. Following is a discussion o f various factors that may have affected 
the outcome o f this study.
1) Only support group members o f the Scleroderma Foundation were 
invited to participate. It might be reasonable to assume that individuals who 
participate in support groups are more likely to have high intem al locus o f control. 
This is because attending a support group may be considered an action individuals 
take to maintain control o f their health.
2) The participants were all volunteers. This m ight also indicate a greater 
tendency towards a high intem al locus o f control since these volunteers 
dem onstrated a willingness to be involved in activities that relate directly to their 
illness.
3) The low retum  rate also may have affected the results. It is highly 
likely that those individuals who chose to participate in the study were different 
than those who did not participate.
4) The unequal num ber o f participants who scored in the High ILOC 
versus Low ILOC made it difficult to contrast or com pare the two groups. The 
small number o f Low ILOC participants made it particularly difficult to draw 
concrete conclusions regarding the general characteristics o f  the Low ILOC group.
Recom m endations for Further Research
Based on methodological lessons learned from  this study, the researcher 
recom m ends two areas for further research.
1) Careful consideration should be given to  how the powerful others 
subscale is defined. Currently, this subscale is defined as individuals’ belief that
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powerful others such as doctors or other people control their health. However, 
results from this study indicate that individuals w ith a high intemal locus o f 
control may perceive powerful others as sources o f information. If this is the case, 
then individuals who score high on the powerful others sub-scale may not feel that 
doctors or other people control the outcom e o f their illness, rather, they may 
believe that by actively seeking inform ation from  “knowledgeable others” they 
have increased their personal control over the outcome o f their illness. If  this
assumption is true then it would redefine the powerful others category and relate it 
closely with the intem al locus o f  control subscale.
2) A second recommendation involves the use o f a larger sample o f 
scleroderma patients who are both in support groups and not in support groups. .
A larger sample and the involvem ent o f  both types of participants would allow the 
researcher to draw more definitive conclusions regarding individuals with a low 
intem al locus o f control, and would also allow  for comparisons and contrasts 
between the groups. In addition, it m ay be possible to identify whether those in 
support groups tend to have a higher intem al locus o f control, compared to those 
not in support groups.
Conclusions
Ultimately, the value of exam ining health locus o f control in relationship 
to coping with illness might be dependent upon the answer to two questions.
First, are individuals with a high intem al locus o f  control more likely to cope 
effectively with an illness than individuals w ith a low intem al locus o f control? 
Second, if  individuals are found to have a low  intem al locus o f control, are there
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techniques available that have been proven effective in increasing their internal 
locus o f control?
In regard to the first question, results from this study indicate that 
individuals with a high internal locus o f control do indeed have a greater variety 
o f positive coping mechanisms in relationship to their illness. The answer to the 
second question is not quite so clear, since studies related to changing locus o f 
control have not been conducted in medical or health care settings with people 
suffering from chronic illness. However, previous studies in academic settings 
have indicated that an individual’s locus o f  control can be changed through the 
use o f therapeutic techniques.
Researchers in one study offered short-term therapy to college students 
who tested low for internal locus o f control. The therapy was targeted toward 
eliminating self-defeating behaviors. After administering the short-term therapy, 
the students were re-tested, and their internal locus o f control scores were 
substantially higher. O ther studies within an academic setting have revealed 
sim ilar findings (Lefcouit, 1982). These results are significant and should be 
applied within a health care setting. Studies directly investigating the ability to 
change a person’s health locus o f control should be conducted with individuals 
who suffer from chronic illness. Inform ation from  these studies could be applied 
to individuals with low internal locus o f control scores, thus allowing them  to 
develop a higher level of internal locus o f control. U ltim ately a higher internal 
locus o f  control would result in the developm ent o f  m ore positive coping 
mechanisms.
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A ppendix A
M ultidim ensional Health Locus o f  Control Survey
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M ULTIDIM ENSIONAL H EALTH  LOCUS OF CONTROL SURVEY
Instructions: Each item below is a be lie f statem ent about your illness with which you may agree o r 
disagree. B eside each statem ent is a  scale w hich ranges from  I (strongly disagree) to 6  (strongly 
agree). For each item we would like you to circle the num ber that represents the extent to which 
you agree o r disagree with that statem ent. P lease m ake sure that you answer EV ERY  ITEM  and 
that you circle ONLY  O N E num ber per item . T his is a m easure o f  your personal beliefs, 
obviously, there are no right o r wrong answ ers. T hank you!
l=Strongly Disagree 
2=Moderately Disagree 
3=Slightly Disagree
4=Slightly Agree 
SssModerately Agree 
6=Strongly Agree
I  ^  
g g l l
f  I
f l l l f |CO • <
1. I f  m y cond ition  w o rs e n s , it is m y  o w n  b eh a v io r  w hich  
d e te rm in e s  ho w  so o n  I  will fee l b e t te r  a g a in . 1 2 3 4 5 6
2. As to  m y co nd ition , w h a t  will b e  will b e . 1 2 3 4 S 6
3. I f  I s e e  m y d o c to r  reg u la rly , I  am  le s s  likely to  h av e  
p ro b lem s w ith  m y cond ition . 1 2 3 4 5 6
4. M ost th in g s  th a t  a f fe c t m y co n d itio n  h a p p e n  to  m e  by 
c h a n c e . 1 2 3 4 5 6
S. W h e n e v e r  m y condition  w o rse n s , I s h o u ld  c o n su lt  a  
m edica lly  tra in e d  p ro fessio n al. 1 2 3 4 5 6
6. I a m  d irec tly  re sp o n sib le  fo r m y  co n d itio n  g e ttin g  b e t te r  o r  
w o rse . 1 2 3 4 5 6
7. O th e r  p eo p le  p lay a  big ro le  in w h e th e r  m y  co n d itio n  
im p ro v es, s ta y s  th e  s a m e  o r  g e ts  w o rs e . 1 2 3 4 5 6
8. W h a te v e r  g o e s  w ro n g  w ith  m y co n d itio n  is m y  ow n  fau it. 1 2 3 4 5 6
9. Luck p lays a  big p a r t  in d e te rm in in g  h o w  m y  co n d itio n  
im p ro v es. 1 2 3
4 5 6
10. In  o rd e r  fo r  m y co n d itio n  to  im p ro v e , it is u p  to  o th e r  
p e o p le  t o  s e e  th a t  th e  rig h t th in g s  h a p p e n .
1 2 3 4 5 6
11. W h a te v e r  im p ro v em en t o c c u rs  w ith  m y  co n d itio n  is large ly  
a  m a tte r  o f  g o o d  fo r tu n e .
1 2 3 4 5 6
12. T h e  m ain  th in g  w hich  a f fe c ts  m y  c o n d itio n  is w h a t  I  m y se lf 
do . 1 2 3 4 5 6
1 3 .1 d e s e rv e  th e  c red it w h e n  m y co n d itio n  im p ro v e s  a n d  th e  
b lam e  w h e n  it g e ts  w orse . 1 2 3 4 5 6
14. Follow ing d o c to r 's  o rd e rs  to  th e  le t te r  is th e  b e s t  w a y  to  
k ee p  m y cond ition  from  g e ttin g  a n y  w o rs e .
1 2 3 4 5 6
15. I f  m y cond ition  w o rse n s , its  a  m a t te r  o r  f a te . 1 2 3 4 5 6
16. I f  I a m  lucky, m y condition  will g e t  b e t te r . 1 2 3 4 5 6
17. I f  m y co n d itio n  ta k e s  a  tu rn  fo r  t h e  w o rs e ,  it is b e c a u s e  I 
h a v e  n o t  b e e n  tak ing  p ro p e r  c a re  o f  m y self. 1 2 3
4 5 6
18. T h e  ty p e  o f  help  I re ce iv e  from  o th e r  p e o p le  d e te rm in e s  
h o w  s o o n  m y cond ition  im proves. 1 2 3 4 5 6
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Appendix B 
Narrative Response Questionnaire
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NARRATIVE RESPONSE QUESTIONNAIRE
D irections: P lease answ er each question in  as m uch detail as possible. W e are interested in you 
“story”- your beliefs and perceptions regarding this disease. I f  you prefer, you may type your 
responses on separate sheets o f  paper. T hank  you!
1. Please explain what you believe caused your scleroderma.
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2. How has Scleroderma affected your life?
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3. Please describe in as much detail as possible, the actions you 
are currently taking to cope with your illness. (Examples: 
walking the dog, reading a book on Scleroderma, attending a 
support group, taking vitamin supplements, meditating, 
praying, eating more nutritiously, finding Scleroderma 
information on the computer, taking an exercise class, talking 
to friends and family, etc.)
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A ppendix C 
Dem ographic Inform ation Page
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Demographic Information
Note: Completion o f  each question on this page is voluntary. Your 
responses w ill be greatly appreciated. Thank you!!
1. Gender
.Female
Male
2. Age
3. Are you:
.Married
.Single
.Living with a significant other/domestic partner
4. Race/Ethnicity
.Asian ______Native American
.Hispanic or Latino  Caucasian
African American_____________Other
5. Highest level of education completed
 Some High School ______High school
 Associate Degree ______Vocational/Technical
 Some College ______College Degree
 Graduate/Professional
6. How long have you been diagnosed with scleroderma?
______________  Years
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(continued on back)
7. Have you been diagnosed with:
 Localized Scleroderma - (localized involves only the
skin)
 Systemic Scleroderma - (systemic involves the skin and
intemal organs)
 Not sure
8. How long have you been attending a support group since 
your diagnosis? (This refers to all support groups, not just 
the current one you are attending)
______________  Years
9. How many doctors/health professionals you are currently 
seeing? (Within the past six months) Check all that apply
 Rheumatologist ______Dermatologist
 Cardiologist ______Internist
 Pulmonologist ______Physical Therapist
 Nutritionist/Dietician ______Dentist
 Naturopathic Physician
Herbalist/Alternative
_Ophthalmologist/Optometrist
_Psychologist/Therapist
Other (please specify)
10. How would you rate your overall health?
 Excellent
 Good
 Fair
 Poor
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A ppendix D 
Participant and Facilitator Cover Letter
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July 9, 2002
Dear Facilitator:
Thank you for agreeing to participate in my study and distribute the enclosed 
information. I want to provide you with a little more information about myself, I 
am a graduate student in Health Promotion at the University o f Montana. I am 
conducting a study in order to receive my M aster’s Degree at the end o f the 
summer. I became interested in the subject o f scleroderma when my mother was 
diagnosed with the disease several years ago. M y study focuses on exploring 
individuals’ approaches to coping with scleroderma as it relates to their 
perceptions of control over their illness.
I appreciate your willingness to distribute the enclosed individual packets to 
members o f your support group who agree to voluntarily participate. You also 
have the option o f participating by filling out a packet. Each individual packet has 
instructions and will guide the members through the process o f filling out the 
information.
You are not responsible for collecting or mailing the com pleted information. 
Participants are provided with a stamped self addressed envelope. I have enclosed 
instructions for you regarding distribution. Feel free to contact me if you have 
additional questions or com ments. I would be happy to provide the results of my 
study once it is complete. Thank you again for your participation in my study.
Sincerely,
Karen Elliott
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July 9, 2002
D ear Participant:
M y nam e is Karen Elliott and I am a graduate student in Health Promotion at the 
University o f Montana. I am  currently conducting a study in order to receive my 
M aster’s Degree at the end of the summer. I became interested in the subject o f 
scleroderma when my mother was diagnosed with the disease several years ago. 
M y study focuses on exploring individuals’ approaches to coping with 
scleroderm a as it relates to their perceptions of control over their illness.
I would appreciate your participation in the study through completion of the 
inform ation in the enclosed packet. Instructions are included with the survey, 
questionnaire and demographic page. I will provide the results o f my study to 
your support group facilitator once it is com plete. Thank you again for your 
participation in my study.
If you have questions about the study or would like to contact me for more 
inform ation, I can be reached at:
Karen Elliott
1500 M cD onald Avenue 16B 
M issoula, M T 59801 
(406) 829-0363 
kelliottOl @ m sn.com
Sincerely,
Karen Elliott
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Appendix £
Participant and Facilitator Instructions
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PARTICIPANT INFORMATION 
n N F O R M A T lO N  REGARDING STUDYF
You are asked to participate in a research study conducted by Karen Elliott from 
the University o f M ontana, Departm ent o f Health and Human Performance. 
Results from this study will be assessed in my m aster’s thesis.
You were selected as a possible participant because you are a current m ember o f a 
scleroderm a support group affiliated with the Scleroderma Foundation.
FTHE PURPOSE O F TH E STU D Y F
There is a lack o f inform ation regarding scleroderma and individuals’ abilities to 
cope and deal with their disease. The purpose o f this study is to  describe 
individuals’ approaches to coping with scleroderma as it relates to their 
perceptions o f control over their illness.
FPRO CEDURESF
1. Read the instructions.
2. Com plete the survey.
3. Complete the questionnaire, use additional pages if  necessary.
4. Place the survey, questionnaire responses, and demographic page into the self- 
addressed stamped envelope.
5. M ail the envelope back to me. Please do not put your name on any o f the 
information, including the envelope.
Thank You!
FPOTENTIAL RISK S AND D ISCO M FO R TSF
The survey and questionnaire ask participants to respond to questions based on 
their perceptions o f their illness. These questions may be sensitive or 
uncom fortable to some.
(continued on back)
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FPOTENTIAL BENEFITSF
This study will provide greater understanding o f scleroderma by explaining the 
role that perceptions o f control o f the disease affects individuals’ ability to cope 
with the disease. Information from this study will be shared w ith scleroderma 
support group members, group facilitators and the Scleroderma Foundation.
rC O N FID EN TIA LITY F
Participants are asked to not put their name on any o f  the information to be sent 
back. In addition, since the participants are approached by the support group 
facilitator, the researcher has no inform ation regarding m em bers' names.
FPARTICIFATION AN D  W ITH DRAW ALF
You can choose whether to be in this study or not. If you volunteer to be in this 
study, you may withdraw at any tim e without consequences o f kind. Participation 
is strictly voluntary.
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PACKET DISTRIBUTION INFORMATION
riN FO R M A T IO N  REGARDING STU D YF
There is a lack o f information regarding scleroderma and individuals’ abilities to 
cope and deal with their disease. The purpose o f this study is to describe 
individuals’ approaches to coping with scleroderma as it relates to their 
perceptions o f control over their illness.
You are asked to participate in a research study conducted by Karen Elliott from 
the U niversity o f M ontana, Departm ent o f Health and Human Performance. 
Results from this study will be used in my m aster’s thesis.
FPRO CEDURESF
1. Please make the enclosed individual packets available to your support group. 
How you distribute them is up to you.
2. Please ask them to follow the instructions contained in each packet.
FThat is the extent o f your role in this study, thank you for agreeing to distribute 
the inform ation to individual members. You are not responsible for collecting or 
mailing any com pleted information, that is the responsibility o f the participant.
F If you have any questions or concern regarding your role or the information 
please feel free to contact me.
FResults from this study will be m ade available to you to share with your support 
group members.
Thank you!
Karen Elliott
1500 M cDonald Avenue 16B 
M issoula M T 59801 
(406) 829-0363 
kelliottOl @ msn.com
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Appendix F 
Institutional Review Board Approval
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The University of Montana <4 
INSTmmONAL R E V I E W  BOA]EÜD(IRB) :
RECEIVED
foi«A4W
2002
cbuckust
z'i'TTi' ecmpteted copy of this Checklist, Indndlmg any tcqnifed jnadiiiicniit, fiv each com e unohring human sutjectSL
,_:c IF3 iceso monthly to evatuam proposals, and approvalis granted for one academic year. Sec 1R3 CuldeHntj and
iVoceefctres fig details.
Project DiretAor Karen Elliott 
Signature:
JD epL:H SE_
Co-Dtrectoi(3):_
Jhone: 829-0363 
_Date: ây-J2S-'OJL
. Dept_:_ JPhone:
Trqjsc: Title: Internal Health Locus o f Control: A Pescrintion ofHiah and Low Orientation and 
Apt>roaefac3 to Coping with Scleroderma
Prqiec: Description: The tmrpose of this Jtudv is to describe individnala’ approaches to coping with their 
ffloess as h relates to their health locus of control.
AH investigators on this project most complete the NIH setf-siody course on protection of human research snbjecta. 
Ceitificatian: IW e have completed the course - (Use additional page if necessary)
Signange  Date Sguamre. \  \  Date
ù)'2ùrCXl  _________ iZ ___
Students Only:
Faculty Supervisor Dr. K. Ana Sondatt. __Dept: HHP JPhone: 243-5215
Signature:
(My stgnature%onSrtns that I have read the 
represents the planned research and that I
and attachments and agree Aat it accurately 
this research ptctfect.)
For QtB Use Only
IR3 Determinatioa:
 Approved Exemption from Review
^iC A pproved  by  Administrative Review d , on
J a C i  I , Z J f o Z .
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The University of
Montana Office of the Vice President Research and Development 
University Hail 116 
243-6670 
243-6330 PAX
To: investigators w ith research invoXving human subjects
From: J . A. Rudbach, IRB Chair 
RE: IRB approval of yoar proposal
t :is study has been ^proved on the date that the **Checldist” was signed. If die study requires an 
Infonned Consent Form, please use the "signed and dated" ICF as a  ̂ master" for pngiaring copies 
for your study. Approval is granted and continues for one year; if  the study runs mote than one year 
a continuation must be requested. Also, you are required to notify the IRB if diere are any 
significant changes or if  unanticipated or adverse events occur dunng the study. Please notify die 
3 .3  \A*en you complete fois stuoy.
Cl
Rudbach
attachment(s)
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
